QUBT Stock Analysis: Quantum Computing | NASDAQ
Computer Hardware | NASDAQ, USA | Market Cap: 1.852m USD | 12M Return: -64.5% | US74766W1080 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 57.5M
Qual. Beats: 0
Rev. Trend: 74.2%
Qual. Beats: 2
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Quantum Computing Inc. (NASDAQ: QUBT) is a U.S.-based integrated photonics company that supplies quantum machines and optical components to commercial and government customers. Its core technology centers on thin-film lithium niobate (TFLN), a material widely used in photonic integrated circuits for high-speed electro-optical modulation and frequency conversion. The company produces chips for electro-optical modulators, periodically poled devices, and micro-ring resonator cavities.
QUBT is also developing the Entropy Quantum Computer (EQC), which applies its Core Photonics Technology to complex optimization problems. Alongside this, the company offers Emucore and Neurawave, reservoir computing systems aimed at recurrent neural network applications - a class of machine learning architectures that are well suited to photonic hardware because of their parallel, time-series oriented processing. Additional products include LiDAR systems designed to operate in adverse weather (fog, snow, ice), a quantum photonic vibrometer for remote sensing, and quantum networking and authentication solutions.
QUBT is headquartered in Hoboken, New Jersey, was founded in 2001, and is classified within the Information Technology sector under the Electronic Equipment & Instruments sub-industry. The company operates in the emerging quantum and photonic hardware market, addressing use cases in optimization, sensing, secure communications, and machine learning inference.
- Government defense contracts awarded for TFLN photonic chips
- Competition intensifies from IBM Google and pure-play quantum peers
- Dilutive equity offerings fund mounting cash burn
| Net Income: -15.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.00 > 0.02 and ΔFCF/TA 16.36 > 1.0 |
| NWC/Revenue: 9.87k% < 20% (prev 132k%; Δ -122k% < -1%) |
| CFO/TA -0.03 > 3% & CFO -43.1m > Net Income -15.0m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 53.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (224.7m) vs 12m ago 58.93% < -2% |
| Gross Margin: -18.92% > 18% (prev 31.18%; Δ -50.10% > 0.5%) |
| Asset Turnover: 0.95% > 50% (prev 0.06%; Δ 0.89% > 0%) |
| Interest Coverage Ratio: -61.34 > 6 (EBIT TTM -14.8m / Interest Expense TTM 242k) |
| A: 0.59 (Total Current Assets 988.3m - Total Current Liabilities 18.6m) / Total Assets 1.64b |
| B: -0.14 (Retained Earnings -235.0m / Total Assets 1.64b) |
| C: -0.01 (EBIT TTM -14.8m / Avg Total Assets 1.03b) |
| D: 33.75 (Book Value of Equity 1.59b / Total Liabilities 47.2m) |
| Altman-Z'' = 38.76 = AAA |
| DSRI: 3.0 (Receivables 14.4m/96.0k, Revenue 9.82m/263k) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 2.40 (AQ_t 0.36 / AQ_t-1 0.15) |
| SGI: 37.35 (Revenue 9.82m / 263k) |
| TATA: 0.02 (NI -15.0m - CFO -43.1m) / TA 1.64b) |
| Beneish M = 25.52 (Cap -4..+1) = D |
As of October 07, 2026, the stock is trading at USD 7.86 with a total of 7,758,041 shares traded. Over the past week, the price has changed by -7.09%, over one month by -4.38%, over three months by -16.12% and over the past year by -64.53%.
Current recommended Stop Loss: 7.20 (which is 8.4% or 1.6 ATR below the current price).
Quantum Computing has received a consensus analysts rating of 4.33. Therefore, it is recommended to buy QUBT.
- StrongBuy: 4
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 18.7 | 137.5% |
P/S = 188.4688
P/B = 1.291
Revenue TTM = 9.82m USD
EBIT TTM = -14.8m USD
EBITDA TTM = -6.51m USD
Long Term Debt = 21.1m USD (estimated: total debt 23.4m - short term 2.29m)
Short Term Debt = 2.29m USD (from shortTermDebt, last quarter)
Debt = 44.5m USD (from shortLongTermDebtTotal, last quarter) + Leases 21.1m
Net Debt = -909.7m USD (calculated: Debt 44.5m - CCE 954.2m)
Enterprise Value = 941.8m USD (1.85b + Debt 44.5m - CCE 954.2m)
Interest Coverage Ratio = -61.34 (Ebit TTM -14.8m / Interest Expense TTM 242k)
EV/FCF = -155.0x (Enterprise Value 941.8m / FCF TTM -6.08m)
FCF Yield = -0.65% (FCF TTM -6.08m / Enterprise Value 941.8m)
FCF Margin = -61.86% (FCF TTM -6.08m / Revenue TTM 9.82m)
Net Margin = -152.5% (Net Income TTM -15.0m / Revenue TTM 9.82m)
Gross Margin = -18.92% ((Revenue TTM 9.82m - Cost of Revenue TTM 11.7m) / Revenue TTM)
Gross Margin QoQ = -21.01% (prev -19.53%)
Tobins Q-Ratio = 0.57 (Enterprise Value 941.8m / Total Assets 1.64b)
Interest Expense / Debt = 0.54% (Interest Expense 242k / Debt 44.5m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -11.7m (EBIT -14.8m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 43.58 (Total Current Assets 988.3m / Total Current Liabilities 22.7m)
Debt / Equity = 0.03 (Debt 44.5m / totalStockholderEquity, last quarter 1.59b)
Debt / EBITDA = 139.7 (negative EBITDA) (Net Debt -909.7m / EBITDA -6.51m)
Debt / FCF = 149.7 (negative FCF - burning cash) (Net Debt -909.7m / FCF TTM -6.08m)
Total Stockholder Equity = 1.42b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.45% (Net Income -15.0m / Total Assets 1.64b)
RoE = -1.06% (Net Income TTM -15.0m / Total Stockholder Equity 1.42b)
RoCE = -1.03% (EBIT -14.8m / Capital Employed (Equity 1.42b + L.T.Debt 21.1m))
RoIC = -0.72% (negative operating profit) (NOPAT -11.7m / Invested Capital 1.62b)
WACC = 5.06% (E(1.85b)/V(1.90b) * Re(5.17%) + D(44.5m)/V(1.90b) * Rd(0.54%) * (1-Tc(0.21)))
Discount Rate = 5.17% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 96.77 | Cagr: 71.68%
[DCF] Fair Price = unknown (Cash Flow -6.08m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.0 | # QB: 0
Revenue Correlation: 74.18 | Revenue CAGR: 155.5% | SUE: 1.80 | # QB: 2
EPS current Quarter (2026-09-30): EPS=-0.06 | Chg30d=+25.00% | Revisions=+25% | Analysts=3
EPS current Year (2026-12-31): EPS=-0.23 | Chg30d=+29.30% | Revisions=+0% | GrowthEPS=+28.0% | GrowthRev=+4032.3%
EPS next Year (2027-12-31): EPS=-0.24 | Chg30d=+37.71% | Revisions=+25% | GrowthEPS=-1.4% | GrowthRev=+85.9%
[Analyst] Revisions Ratio: +40% (up=2, down=0)